Blood · 1991 · 159 citations · 24 references
MedicineHematologyPathologyHemostasisPathophysiologyBleeding DisordersCoagulation DisordersCoagulation Factor DeficienciesHemostatic DisordersThrombosisThrombotic DisordersDisorders Of FibrinolysisHereditary Bleeding DisordersPlasminogen ActivatorsPrimary Bleeding DisordersRare Bleeding Disorders
A 36-year-old patient was investigated for a lifelong history of epistaxis and delayed bleeding after minor surgeries. Deficiencies or abnormalities of the coagulation system, of platelet function, or of factor XIII and alpha-2-antiplasmin were excluded. Consistently, however, over a period of 7 years, a high basal euglobulin fibrinolytic activity was observed that was characterized by a high tissue-type plasminogen activator (t-PA) activity, normal t-PA antigen, and undetectable plasminogen activator inhibitor type-1 (PAI-1) antigen and activity. The high specific activity of t-PA (640,000 IU/mg) and the minimal amounts of t-PA/PAI-1 complexes detected by fibrin zymography suggest that in this patient all t-PA was active. This is in striking contrast to normal plasma, where the majority of t-PA is complexed to PAI-1. Thus, in this patient, a severe deficiency of PAI-1 is associated with a delayed type bleeding tendency. Our observation underscores the importance of plasma PAI-1 for the stabilization of the hemostatic plug.
24
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
Anders Hamsten, Göran Walldius, Alfred Szamosi et al. · The Lancet · 1987 · 1.5K citations
I. M. Nilsson, H Ljungnér, Lilian Tengborn · BMJ · 1985 · 339 citations · Full text
Medicine, Hematology, Hemostasis +16